Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Please check the “Other Notices” tab on the NIH Guide for Grants and Contracts to see updates to NIH policies that ensure alignment with the Administration’s priorities.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status	Expiration Date Sort descending	Program Official
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer	NOT-CA-22-085			09/08/2025
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases	NOT-DA-22-048			09/08/2025
Notice of Special Interest (NOSI): Factors impacting how Time-Restricted Eating (TRE) influences cancer-related outcomes	NOT-CA-24-073			09/08/2025	Edward Sauter, M.D., Ph.D.
Notice of Special Interest (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research	NOT-CA-24-074			09/08/2025	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Biology of Bladder Cancer	PAR-25-128 (R21 Clinical Trial Optional)	R21	Clinical Trial Optional	09/08/2025	Howard L. Parnes, M.D.
Biology of Bladder Cancer	PAR-25-129 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	09/08/2025	Howard L. Parnes, M.D.
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk	NOT-CA-25-002			09/08/2025	Edward Sauter, M.D., Ph.D.
Notice of Correction to PAR-25-104, Cancer Prevention and Control Clinical Trials Planning Grant Program	NOT-CA-25-023 (R34 Clinical Trials Optional)	R34		10/26/2025	Goli Samimi, Ph.D., M.P.H.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes	PAR-25-095 (R01 Clinical Trial Not Allowed)	R01	Clinical Trial Not Allowed	09/08/2026	Wendy Wang, Ph.D., M.Sc.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers	PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed)	R00, K99	Clinical Trial Not Allowed	10/15/2026